14 CLINICAL STUDIES

Archived from the original on 3 April 2007. ^ "FDA approves Cialis to treat benign prostatic hyperplasia".

Interaction	Effect	Recommendations
Nitrates	Severe hypotension	Avoid combination
Alpha-blockers	Lower blood pressure	Use with caution, monitor BP
CYP3A4 inhibitors	Increased Cialis levels	Adjust dosage accordingly
Grapefruit juice	Potentially increases levels	Limit intake

Archived from the original on 18 January 2017. ^ a b Elliott S (10 January 2006). Archived from the original on 22 April 2018. "Viagra and the Battle of the Awkward Ads".

How much is Cialis online?

[citation needed] In China, CMOAPI is the largest manufacturer of Tadalafil powder. Tadalafil is being studied for treating Peyronie's disease. Archived from the original on 1 December 2020. Archived from the original on 20 January 2021. ^ "Cialis 10mg film-coated tablets - Summary of Product Characteristics (SmPC)".

1.2 Benign Prostatic Hyperplasia

Archived from the original on 21 September 2019. Archived from the original on 6 March 2023. Archived from the original on 7 January 2021. Archived from the original on 20 September 2020. ^ British national formulary: BNF 76 (76 ed.). "First they tried to play it safe; Ads for erectile dysfunction drug Cialis bared all - including a scary potential side effect. It was risky but it has paid off".

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	5mg	30 + 4 Pills	53.56€ 51.01€	Buy
Cialis Black	80mg	120 + 8 Pills	264.77€ 252.16€	Buy
Cialis Generic	20mg	270 + 10 Pills	335.21€ 319.25€	Buy
Cialis Generic	5mg	90 + 6 Pills	115.91€ 110.39€	Buy
Cialis Original	20mg	12 Pills	78.32€ 74.59€	Buy
Cialis Generic	10mg	20 Pills	48.23€ 45.93€	Buy
Cialis Soft Tabs	20mg	180 + 8 Pills	353.17€ 336.35€	Buy
Cialis Generic	60mg	180 + 10 Pills	313.11€ 298.20€	Buy
Cialis Original	20mg	92 + 4 Pills	377.99€ 359.99€	Buy
Cialis Generic	40mg	20 Pills	59.47€ 56.64€	Buy
Cialis Original	20mg	22 + 2 Pills	129.20€ 123.05€	Buy
Cialis Professional	40mg	120 + 4 Pills	436.68€ 415.89€	Buy

Archived from the original on 14 December 2019. "Two Pills Look to Topple Viagra's Reign in Market; Levitra Expects Approval Next Month, Cialis Later This Year".

16.1 How Supplied

Archived without prescription cialis soft from the original on 24 February 2012. "2,5-Diketopiperazines: synthesis, reactions, medicinal chemistry, and bioactive natural products". "An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals". Archived from the original on 17 October 2014. Archived from the original on 29 April 2015.

17.10 Sexually Transmitted Disease

^ "FDA approves tadalafil for pulmonary arterial hypertension". Archived from the original on 13 November 2014. "The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. Archived from the original on 16 December 2017. "Drugs giant says its new pill will pack more punch than rival Viagra". Archived from the original on 24 January 2021. Archived from the original on 10 September 2015. Archived from the original (PDF) on 29 August 2021.

Study / Source	Effectiveness (%)	Comments
Clinical Trial 2022	70-80%	Used in men with ED
Patient Surveys	75%	Reported satisfaction with Cialis
Comparative Studies	Slightly better than Viagra	Longer duration of effect
Real-world Data	78%	Consistent effectiveness

Archived from the original on 9 November 2021. "Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie's disease: a retrospective comparative analysis". "PD21-09 Daily Tadalafil Therapy: A New Treatment Option for Peyronie's Disease?". Eli Lilly and Company announced in a press release that it has made an agreement with Sanofi to pursue regulatory approval of over-the-counter (OTC) Cialis (tadalafil). Currently only available by prescription, Lilly’s Cialis treats erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). The Food and Drug Administration (FDA) approved the drug in 2003 and it is currently available in more than 120 countries. Vincent Warnery, SVP of Global Consumer Healthcare Division at Sanofi, said the agreement was an “opportunity to forge an industry-leading partnership.” David Ricks, SVP at Lilly said, "Switching a medicine to over-the-counter is a highly regulated process that is data-driven and scientifically rigorous. Together with Sanofi, we look forward to working closely with regulatory authorities to define the proper actions and necessary precautions to help patients use over-the-counter Cialis appropriately." The two companies have agreed to several provisions. Sanofi acquires the right to file for OTC approval in the U.S., Canada, Australia, and Europe. Following regulatory approvals, Sanofi is authorized to commercialize OTC Cialis. Due to expiring patents, the companies did not reveal timetables for the partnership. However, Cialis is due to lose its patent in 2017 in the U.S. and Europe. Sanofi and Lilly did not release financial details. The European Medicines Agency (EMA) approved Cialis in 2002 and the U.S. approved it in 2003 for ED.

• Cialis introduction changed the landscape of erectile dysfunction treatment.
• It offered an alternative with longer duration than prior PDE5 inhibitors.
• Market acceptance was driven by favorable patient and clinician feedback.
• Some men prefer Cialis due to reduced planning for sexual activity.
• The drug's patent provided Lilly a commercial advantage for years.
• Extensive advertising targeted both physicians and consumers.
• Patient support groups often discuss experiences with Cialis.
• Alternative ED treatments include injections, vacuum pumps, and surgery.
• Cialis fits a broad spectrum of ED severity levels.
• Diabetes, hypertension, and heart disease are common conditions with Cialis use.
• Lilly continues efforts to educate about safe sexual health practices.
• Ongoing clinical trials explore broader uses of tadalafil.

The FDA approved it for BPH in 2011.

13. Nonclinical Toxicology

Archived from the original on 30 August 2024. ^ "Tadalafil Drug Usage Statistics, United States, 2013 - 2022". "Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis". "A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction". ^ "Ppsynvi (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial Hypertension (PAH)".

2.1 CIALIS for Use as Needed for Erectile Dysfunction

Archived from the original on 26 November 2021. "Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US". ^ "Non-Arteritic Anterior Ischemic Optic Neuropathy - Brigham and Women's Hospital". Archived from the original on 28 October 2021. ^ Penedones A, Alves C, Batel Marques F (February 2020). The drug is approved in 120 countries for ED and other conditions. Lilly says that sales of Cialis were $2.16 billion worldwide in 2013. Since its launch, Cialis has earned over $14 billion treating more than 45 million men. Cialis is administered orally as needed in dosage strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg for ED, and 5 mg for BPH. IMS Health has released a report detailing the global market for generics from 2012 to 2017.

• Lilly is an American pharmaceutical company founded in 1876.
• Eli Lilly developed Cialis as a competitor to Viagra.
• Cialis is marketed under the brand name “Cialis” internationally.
• The drug became a best-seller due to its long-lasting effects.
• Tadalafil, Cialis’s active ingredient, selectively inhibits PDE5 enzyme.
• Lilly conducted extensive clinical trials to ensure Cialis’s safety.
• Cialis has been studied for off-label uses such as pulmonary hypertension.
• Patent protections have allowed Lilly to secure market exclusivity.
• Lilly provides patient support programs for Cialis users.
• The company emphasizes Cialis's effectiveness and safety profile.
• Cialis helped Lilly diversify beyond insulin and psychiatric drugs.
• Women's use of Cialis is not FDA approved and requires caution.

It says that generics will dominate the market by 2017, accounting for 63 percent market share.

7.3 Potential for CIALIS to Affect Other Drugs

In October 2011, the US FDA approved tadalafil[33] to treat the signs and symptoms of benign prostatic hyperplasia. Benign prostatic hyperplasia is a condition in which the prostate gland becomes enlarged, obstructing the free flow of urine. Symptoms may include sudden urges to urinate (urgency), difficulty in starting urination (hesitancy), a weak urine stream, and more frequent urination—especially at night. The FDA has also approved tadalafil for the treatment of both benign prostatic hyperplasia and erectile dysfunction where the two conditions co-exist. In the United States, the FDA relaxed rules on prescription drug marketing in 1997, allowing advertisements targeted directly to consumers.

17.3 Cardiovascular Considerations

[34] Lilly-ICOS hired the Grey Worldwide Agency in New York, part of the Grey Global Group, to run the Cialis advertising campaign. [35] Marketing for Cialis has taken advantage of its greater duration compared to its competitors in advertisements for the drug; Stuart Elliot of The New York Times opined: "The continuous presence of females in Cialis ads is a subtle signal that the drug makes it easier for them to set the pace with males, in contrast to the primarily male-driven imagery for Levitra and Viagra. "[35] Iconic themes in Cialis ads include couples side by side in matching bathtubs and the slogan "When the moment is right, will you be ready? "[35] Cialis ads were unique among the ED drugs in mentioning specifics of the drug. [36] As a result, Cialis ads were also the first to describe the side effects in an advertisement, as the FDA requires advertisements with specifics to mention side effects. Patent expiration is driving the growth of OTC drugs. Report authors state that developed markets use branded drugs the most. However, emerging markets are ripe for OTC drug sales. Today we announced the acquisition of the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia.

• Cialis has been studied in combination with other ED treatments.
• Research explores effects of Cialis on other vascular diseases.
• The medication’s development highlighted the role of enzyme PDE5.
• Side effect profiles are monitored in post-marketing surveillance.
• Cialis is included in many guidelines as a first-line ED therapy.
• The drug is contraindicated with certain cardiac medications.
• Cost and accessibility remain concerns for some patients.
• Generic versions have improved affordability worldwide.
• Cialis may improve confidence and emotional well-being.
• Ongoing trials explore new indications beyond ED and BPH.
• Patient adherence to therapy is critical for results.
• Lilly’s commitment to sexual health research continues.

This will strengthen our presence in Latin America and support our growth in key markets across the region.

3. Dosage Forms and Strengths

One of the first Cialis ads aired at the 2004 Super Bowl. [36] Just weeks before the Super Bowl, the FDA required more possible side effects to be listed in the advertisement, including priapism. [36] Although many parents objected to the Cialis ad being aired during the Super Bowl, Janet Jackson's halftime "wardrobe malfunction" overshadowed Cialis. [36] In January 2006, the Cialis ads were tweaked, adding a doctor on screen to describe side effects and only running ads where more than 90 percent of the audience are adults, effectively ending Super Bowl ads. [34] In 2004, Lilly-ICOS, Pfizer, and GlaxoSmithKline spent a combined $373.1 million to advertise Cialis, Viagra, and Levitra respectively.

Dive Brief:

[36] Cialis has sponsored many sporting events, including the America's Cup and the PGA Tour, once being title sponsor of the PGA Tour Western Open tournament. In Australia, tadalafil is subsidized through the Repatriation Pharmaceutical Benefits Scheme (RPBS) for patients with a specific accepted war- or service-related disability. In the US, a generic version of tadalafil is available. [39] While some health insurance providers cover at least part of the cost (typically limiting the number of doses covered per month), many providers, including those operating under Medicare Part D, do not cover the cost of medications prescribed for erectile dysfunction. In the UK, a generic version of tadalafil became available in November 2017, reducing its price per pill, and is available through the NHS. We will work closely with Eli Lilly & Co to transfer the manufacturing of the product to our Chilean production site. There is a huge market potential for the Cialis indication in these countries. This acquisition is a significant milestone for our team. Integrating Cialis® into our Chilean production site will not only enhance our manufacturing capabilities but also ensure a steady supply for key Latin American markets. Looking forward to working closely with Lilly to make this transition smooth and successful.

Drug Label Information

"Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis". ^ "FDA Announces Revisions to Labels for Cialis, Levitra and Viagra". U.S. Food and Drug Administration (FDA). Archived from the original on 22 October 2016.

See real-time updates

"Droperidol is predominantly metabolized by human CYP3A enzymes". "Tadalafil (Cialis) and Vardenafil (Levitra) Recently Approved Drugs for Erectile Dysfunction". Archived from the original on 14 July 2016. "Potency, selectivity, and consequences of nonselectivity of PDE inhibition". "Deep Pockets + Intense Research + Total Control = The Formula -- Bothell Biotech Icos Keeps The Pipeline Full Of Promise". Another step that fuels our company’s growth.

Owner

Fabienne Heyne
[email protected]

Design & Implementation

Jonas Bünter
www.jonas.work

Photography

Angelika Annen
www.angelikaannen.ch